Related Experiment Video
Updated: Jun 5, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Turning 18 with congenital heart disease: prediction of infective endocarditis based on a large population
Carianne L Verheugt1, Cuno S P M Uiterwaal, Enno T van der Velde
1Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.
Insights
A new risk score can predict infective endocarditis (IE) in adults with congenital heart disease. This tool uses six clinical factors to identify high-risk patients for tailored surveillance and early detection.
Area of Science:
- Cardiology
- Public Health
- Clinical Prediction Modeling
Background:
- Adults with congenital heart disease (ACHD) have an elevated risk of infective endocarditis (IE).
- Empirical risk estimates for IE in ACHD patients are currently lacking.
- Predicting IE risk is crucial for timely intervention and management.
Purpose of the Study:
- To develop and validate a prediction model for infective endocarditis (IE) in adults with congenital heart disease (ACHD).
- To identify key predictors of IE occurrence in this vulnerable population.
- To create a clinically applicable risk score for IE in ACHD patients.
Main Methods:
- Utilized data from the CONCOR national registry for ACHD patients.
- Employed Cox proportional hazards model and bootstrapping for model derivation.
- Identified predictors including gender, type of congenital heart defect, and childhood complications.
Main Results:
- A cohort of 10,210 ACHD patients was analyzed over 220,688 patient-years.
- 2.3% of patients developed adult-onset IE.
- A prediction model incorporating six clinical parameters accurately stratified risk up to age 60, with low-risk (<3%) having <1% incidence and high-risk (≥3%) having 6% incidence by age 40.
Conclusions:
- A simple, six-parameter clinical prediction model can accurately identify ACHD patients at low or high risk for IE.
- The validated model can guide personalized medical surveillance and educational counseling.
- Application of this model may help prevent IE or facilitate its early detection in ACHD patients.
Aims:
The risk of infective endocarditis (IE) in adults with congenital heart disease is known to be increased, yet empirical risk estimates are lacking. We sought to predict the occurrence of IE in patients with congenital heart disease at the transition from childhood into adulthood.
Methods And Results:
We identified patients from the CONCOR national registry for adults with congenital heart disease. Potential predictors included patient characteristics, and complications and interventions in childhood. The outcome measure was the occurrence of IE up to the age of 40 and 60. A prediction model was derived using the Cox proportional hazards model and bootstrapping techniques. The model was transformed into a clinically applicable risk score. Of 10 210 patients, 233 (2.3%) developed adult-onset IE during 220 688 patient-years. Predictors of IE were gender, main congenital heart defect, multiple heart defects, and three types of complications in childhood. Up to the age of 40, patients with a low predicted risk (<3%) had an observed incidence of less than 1%; those with a high predicted risk (≥3%) had an observed incidence of 6%. The model also yielded accurate predictions up to the age of 60.
Conclusion:
Among young adult patients with congenital heart disease, the use of six simple clinical parameters can accurately predict patients at relatively low or high risk of IE. After confirmation in other cohorts, application of the prediction model may lead to individually tailored medical surveillance and educational counselling, thus averting IE or enabling timely detection in adult patients with congenital heart disease.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis IV: Nursing Management
Endocarditis III: Medical Management
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

